 <h1>Arikayce Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>amikacin liposome</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li>
<li>FAQ</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about amikacin liposome. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Arikayce.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to amikacin liposome: inhalation suspension</i></p><h3>Warning</h3><p class="blackboxWarning-title">Inhalation route (Suspension)</p><p>Amikacin liposome has been associated with an increased risk of respiratory adverse reactions, including, hypersensitivity pneumonitis, hemoptysis, bronchospasm, and exacerbation of underlying pulmonary disease that have led to hospitalizations in some cases.</p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, amikacin liposome (the active ingredient contained in Arikayce) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking amikacin liposome:</p><p>
<i>More common</i>
</p><ul>
<li>Cough</li>
<li>coughing or spitting up blood</li>
<li>difficulty breathing</li>
<li>dizziness</li>
<li>feeling of fullness in the ears</li>
<li>fever</li>
<li>loss of balance</li>
<li>loss of hearing</li>
<li>noisy breathing</li>
<li>ringing or buzzing in the ears</li>
<li>sore throat</li>
<li>tightness in the chest</li>
<li>trouble hearing</li>
<li>upper airway irritation</li>
<li>voice changes</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Balance disorder</li>
<li>blue lips, fingernails, or skin</li>
<li>change in sputum</li>
<li>chest discomfort or pain</li>
<li>chills</li>
<li>cough producing mucus</li>
<li>general feeling of discomfort or illness</li>
<li>irregular, fast or slow, or shallow breathing</li>
<li>nosebleed</li>
<li>severe pain in the chest</li>
<li>sudden onset of severe breathing difficulty</li>
<li>thickening of bronchial secretions</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of amikacin liposome may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Bone or muscle pain</li>
<li>decreased weight</li>
<li>diarrhea</li>
<li>headache</li>
<li>lack or loss of strength</li>
<li>nausea</li>
<li>rash</li>
<li>unusual tiredness or weakness</li>
<li>vomiting</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Anxiety</li>
<li>change in taste</li>
<li>dry mouth</li>
<li>loss of taste</li>
</ul><p>
<!-- end inhalation suspension --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to amikacin liposome: inhalation suspension</i></p><h3>General</h3><p>The most commonly reported side effects included dysphonia, cough, bronchospasm, and hemoptysis.<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Dysphonia (up to 47%), cough (up to 39%), bronchospasm (up to 29%), hemoptysis (up to 18%), upper airway irritation (up to 17%), exacerbation of underlying pulmonary disease (up to 15%)</p>
<p><b>Common</b> (1% to 10%): Bronchitis, change in sputum, epistaxis, hypersensitivity pneumonitis, pneumonia, pneumothorax, respiratory failure</p>
<p><b>Frequency not reported</b>: Acute respiratory failure, allergic alveolitis, aspiration pneumonia, asthma, atypical pneumonia, bronchial hyperreactivity, chronic obstructive pulmonary disease (COPD) exacerbation, dyspnea, dyspnea exertional, increased sputum, infective exacerbation of bronchiectasis, infective exacerbation of COPD, interstitial lung disease, laryngeal erythema, laryngeal pain, laryngitis, lower respiratory tract infection, lung infection, lung infection pseudomonas, oropharyngeal discomfort, oropharyngeal pain, pharyngeal edema, pharyngeal erythema, pleural effusion infection, productive cough, pneumomediastinum, pneumonia pseudomonas, pneumonitis, prolonged expiration, respiratory tract infection, spontaneous pneumothorax, sputum discolored, throat irritation, throat tightness, upper airway cough syndrome, upper airway inflammation, vocal cord inflammation, wheezing<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Ototoxicity (up to 17%), asthenia (up to 16%), fatigue (up to 16%)</p>
<p><b>Common</b> (1% to 10%): Chest discomfort, exercise tolerance decreased, pyrexia</p>
<p><b>Frequency not reported</b>: Body ache, deafness, exacerbation of underlying disease, hypoacusis, neurosensory deafness, pain, tinnitus, unilateral deafness<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Diarrhea (up to 13%), nausea (up to 12%)</p>
<p><b>Common</b> (1% to 10%): Dry mouth, oral fungal infection, vomiting</p>
<p><b>Frequency not reported</b>: Oral candidiasis, post-tussive vomiting<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Musculoskeletal pain (up to 17%)</p>
<p><b>Frequency not reported</b>: Arthralgia, back pain, muscle spasm, muscle weakness, myalgia<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Balance disorder, dysgeusia, headache, neuromuscular disorder</p>
<p><b>Frequency not reported</b>: Aphonia, dizziness, neuromuscular blockade, peripheral neuropathy, presyncope, vertigo<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Rash</p>
<p><b>Frequency not reported</b>: Drug eruption, maculopapular rash, urticaria<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Anxiety<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Decreased weight<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Frequency not reported</b>: Empyema, pseudomonas infection, sputum purulent<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Frequency not reported</b>: Nephrotoxicity<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Arikayce (amikacin liposome)." Insmed Incorporated, Bridgewater, NJ. </p></div>
<h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2>
<ul>
<li>What type of drug is Arikayce?</li>
</ul>
<div class="more-resources" id="moreResources">
<h2>More about Arikayce (amikacin liposome)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Español</li>
<li>Drug class: aminoglycosides</li>
<li>FDA Approval History</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Arikayce &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Mycobacterium avium-intracellulare, Treatment</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to amikacin liposome: inhalation suspension</i></p><h3>General</h3><p>The most commonly reported side effects included dysphonia, cough, bronchospasm, and hemoptysis.<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Dysphonia (up to 47%), cough (up to 39%), bronchospasm (up to 29%), hemoptysis (up to 18%), upper airway irritation (up to 17%), exacerbation of underlying pulmonary disease (up to 15%)</p><p><b>Common</b> (1% to 10%): Bronchitis, change in sputum, epistaxis, hypersensitivity pneumonitis, pneumonia, pneumothorax, respiratory failure</p><p><b>Frequency not reported</b>: Acute respiratory failure, allergic alveolitis, aspiration pneumonia, asthma, atypical pneumonia, bronchial hyperreactivity, chronic obstructive pulmonary disease (COPD) exacerbation, dyspnea, dyspnea exertional, increased sputum, infective exacerbation of bronchiectasis, infective exacerbation of COPD, interstitial lung disease, laryngeal erythema, laryngeal pain, laryngitis, lower respiratory tract infection, lung infection, lung infection pseudomonas, oropharyngeal discomfort, oropharyngeal pain, pharyngeal edema, pharyngeal erythema, pleural effusion infection, productive cough, pneumomediastinum, pneumonia pseudomonas, pneumonitis, prolonged expiration, respiratory tract infection, spontaneous pneumothorax, sputum discolored, throat irritation, throat tightness, upper airway cough syndrome, upper airway inflammation, vocal cord inflammation, wheezing<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Ototoxicity (up to 17%), asthenia (up to 16%), fatigue (up to 16%)</p><p><b>Common</b> (1% to 10%): Chest discomfort, exercise tolerance decreased, pyrexia</p><p><b>Frequency not reported</b>: Body ache, deafness, exacerbation of underlying disease, hypoacusis, neurosensory deafness, pain, tinnitus, unilateral deafness<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Diarrhea (up to 13%), nausea (up to 12%)</p><p><b>Common</b> (1% to 10%): Dry mouth, oral fungal infection, vomiting</p><p><b>Frequency not reported</b>: Oral candidiasis, post-tussive vomiting<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Musculoskeletal pain (up to 17%)</p><p><b>Frequency not reported</b>: Arthralgia, back pain, muscle spasm, muscle weakness, myalgia<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Balance disorder, dysgeusia, headache, neuromuscular disorder</p><p><b>Frequency not reported</b>: Aphonia, dizziness, neuromuscular blockade, peripheral neuropathy, presyncope, vertigo<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Rash</p><p><b>Frequency not reported</b>: Drug eruption, maculopapular rash, urticaria<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Anxiety<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Decreased weight<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Frequency not reported</b>: Empyema, pseudomonas infection, sputum purulent<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Frequency not reported</b>: Nephrotoxicity<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Arikayce (amikacin liposome)." Insmed Incorporated, Bridgewater, NJ. </p><h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2><ul>
<li>What type of drug is Arikayce?</li>
</ul><h2>More about Arikayce (amikacin liposome)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Español</li>
<li>Drug class: aminoglycosides</li>
<li>FDA Approval History</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Arikayce &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Mycobacterium avium-intracellulare, Treatment</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>